Effective in treating hematologic malignancies.
Can be complicated by graft-versus-host-disease (GVHD).
Graft-versus leukemia and graft-versus-host-disease can be mediated by donor derived T cells that recognize polymorphic minor histocompatibility antigens on recipient cells.